United States - English - NLM (National Library of Medicine)

vettek - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: flunixin injection (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin injection (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin injection is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle : nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of still birth. do not use flunixin injection (flunixin meglumine injection) within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected.

United States - English - NLM (National Library of Medicine)

norbrook laboratories limited - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

United States - English - NLM (National Library of Medicine)

norbrook laboratories limited - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: flunixin injection is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin injection is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin injection is also indicated for the control of inflammation in endotoxemia. horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of partur

United States - English - NLM (National Library of Medicine)

covetrus - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - horse:  flunixin meglumine injectable solution is recommended for the alleviation of inflammation and pain associated with muscoskeletall disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin meglumine injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin meglumine injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunixin meglumine injectable solution within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected. safety horse: a 3-fold intramuscular dose of 1.5 mg/lb of body weight daily for 10 consecutive days was safe. no changes were observed in hematology, serum chemistry, or urinalysis values. intravenous dosages of 0.5 mg/lb daily for 15 days; 1.5 mg/lb daily for 10 days; and 2.5 mg/lb daily for 5 days produced no changes in blood or urine parameters. no injection site irritation was observed following intramuscular injection of the 0.5 mg/lb recommended dose. some irritation was observed following a 3-fold dose administered intramuscularly. cattle: no flunixin-related changes (adverse reactions) were noted in cattle administered a 1x (2.2 mg/kg; 1.0 mg/lb) dose for 9 days (three times the maximum clinical duration). minimal toxicity manifested itself at moderately elevated doses (3x and 5x) when flunixin was administered daily for 9 days, with occasional findings of blood in the feces and/or urine. discontinue use if hematuria or fecal blood are observed.

United States - English - NLM (National Library of Medicine)

vetone/mwi - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: prevail™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: prevail™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail™ is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the inhibition of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use prevail™ (flunixin meglumine injection) within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected.

United States - English - NLM (National Library of Medicine)

mwi veternary supply, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - flunixin meglumine 50 mg in 1 ml - indications    horse : prevail™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse.    cattle : prevail™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail™ is also indicated for the control of inflammation in endotoxemia. contraindications    horse : there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle : nsaids inhibit pr

United States - English - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 100 ml - indication flunazine-s (flunixin meglumine injection) is indicated for the control of pyrexia associated with swine respiratory disease. contraindications there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

United States - English - NLM (National Library of Medicine)

aspen veterinary resources - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: vetameg® 50 mg/ml is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: vetameg® 50 mg/ml is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg® 50 mg/ml is also indicated for the control of inflammation in endotoxemia. horse: there are no known contra-indications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of partu

United States - English - NLM (National Library of Medicine)

mwi veterinary supply co - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: prevail® is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: prevail® is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail® is also indicated for the control of inflammation in endotoxemia. horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flu

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - flunixin as flunixin meglumine - parenteral liquid/solution/suspension - flunixin as flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cow | dog | horse | pigs | bitch | boar | bovine | castrate | colt | donkey | endurance horse | female cattle | filly | foal | g - agalactia | analgesic | anti-inflammatory agent | antipyretic | arthritis | canine parvovirus | disc problems | downer cow syndrome | infections of the respiratory tract | mastitis | metritis | musculoskeletal conditions | acute respiratory infections | antipyretic | arthritis | arthrosis | bone soreness | bronchiseptica | bronchitis | bruising | bursitis | colic | disc pain | external myopathy | inflamation of soft tissues an | inflammatory rheumatic arthrit | joint disease | ligament sprains | mastitis-metritis-agalactia | muscle relaxant | muscle soreness | osteitis | osteoarthritis | parvovirus | pharyngitis | platelet activity | pneumonia | rheumatism | sedative | spasmolytic | sprains | strains | subclinical mastitis | tendon and ligament sprains | tendon sprains | tendonitis | tenosynovitis | tonsillitis | traumatic joint and connective | traumatic swelling | vertebrae pain | vertebrae problems